Archives of Toxicology

, Volume 90, Issue 7, pp 1541–1553

Diesel exhaust: current knowledge of adverse effects and underlying cellular mechanisms

  • Sandro Steiner
  • Christoph Bisig
  • Alke Petri-Fink
  • Barbara Rothen-Rutishauser
Open Access
Review Article

Abstract

Diesel engine emissions are among the most prevalent anthropogenic pollutants worldwide, and with the growing popularity of diesel-fueled engines in the private transportation sector, they are becoming increasingly widespread in densely populated urban regions. However, a large number of toxicological studies clearly show that diesel engine emissions profoundly affect human health. Thus the interest in the molecular and cellular mechanisms underlying these effects is large, especially concerning the nature of the components of diesel exhaust responsible for the effects and how they could be eliminated from the exhaust. This review describes the fundamental properties of diesel exhaust as well as the human respiratory tract and concludes that adverse health effects of diesel exhaust not only emerge from its chemical composition, but also from the interplay between its physical properties, the physiological and cellular properties, and function of the human respiratory tract. Furthermore, the primary molecular and cellular mechanisms triggered by diesel exhaust exposure, as well as the fundamentals of the methods for toxicological testing of diesel exhaust toxicity, are described. The key aspects of adverse effects induced by diesel exhaust exposure described herein will be important for regulators to support or ban certain technologies or to legitimate incentives for the development of promising new technologies such as catalytic diesel particle filters.

Keywords

Diesel engines Diesel particles Ultrafine particles Lung cells Adverse effects 

The diesel engine: opportunity and challenge

In the year 312 BC, the Roman censor Appius Claudius Caecus built the Via Appia, a paved road connecting Rome and Capua. This was the beginning of a process that culminated in a monumental network of around 80,000 km of paved roads connecting the cities of the Roman Empire, which allowed efficient transportation of goods, exchange of information, and movement of troops. The Romans knew very well that cultural and economic development, security and safe supply of food and resources—essentially the concept of a state—rises and falls with the degree of provided mobility.

More than 2000 years later this rule still applies, perhaps even more than ever before, in the globalized world we live in. It is to a large part the invention of thermal engines—first the steam engine in the eighteenth century, then the internal combustion engines in the nineteenth century—that made globalization possible, and the economic, social and governmental structures we live in cannot be imagined without engine-driven industry and transportation.

Despite all the great advantages, the downside of internal combustion engines is evident: Their ubiquitousness has created one of the major challenges for society and the environment—their emissions affect human health on a regional scale, and the earth’s climate even on a global scale. Strikingly, this only began to be fully acknowledged during and after the 1960s, when first attempts to regulate exhaust emissions were undertaken, for instance by the Environmental Protection Agency of the United States (http://www3.epa.gov).

Of all existing internal combustion engines, the diesel engine is among the most popular and is therefore of great concern with respect to the environment and public health. After its invention in the late 1890s, the diesel engine rapidly evolved into a prominent technology for heavy-duty applications in the stationary, marine, railroad and military sectors, but at first did not feature heavily in the private transportation sector. Only in the late 1980s, with the adaptation of turbochargers and the development of common rail direct injection systems, were diesel engines made feasible for the light-duty, private transportation sector. Since then, their popularity has continuously increased, to a large part certainly due to obvious reasons such as their higher durability and higher fuel efficiency compared to gasoline cars. As discussed in detail by Cames and Helmers (2013), there are further, less obvious reasons for their increasing popularity. Most notably, governmental market interventions had (and still have) a strong influence, and it is therefore unsurprising that the trend is not globally uniform but depends on the economic and ecological strategies pursued by different governments. Among the largest car markets, the European Union and India show high and rapidly growing shares of diesel cars, whereas in the USA, China and Japan and Brazil, they are rather a side issue.

With diesel engines penetrating the private transportation sector, their emissions are brought into urban centers, inevitably resulting in a high and continuous exposure of a large part of the population. In 2010, 95 % of the urban atmospheric background mass concentrations of particulate elemental carbon, and between 10 and 35 % of the atmospheric organic carbon mass in the ambient air of Birmingham (UK), could be attributed to diesel engines (Yin et al. 2010). In Delhi, India, many studies have source-appointed PM and found up to 28 percent of total PM originating from diesel vehicles (Pant and Harrison 2012). It is figures like these that bring the health effects of diesel engine emissions into focus, particularly since in many regions of the world (e.g., India) adequate emission legislations are introduced with a significant time lag compared to more developed countries. Not surprisingly in an era of strong scientific, economic and regulatory interest in public health, diesel engine emissions happen to be among the most thoroughly investigated anthropogenic pollutants. This is reflected in the large number of scientific publications in this field, of which only an impression can be given here (Varatharajan and Cheralathan 2012; Brijesh and Sreedhara 2013; Dwivedi et al. 2013; Giakoumis et al. 2013; Myung and Park 2012; Geller et al. 2006; Wierzbicka et al. 2014; Heeb et al. 2013; Heeb et al. 2010; Ashraful et al. 2015; Popovicheva et al. 2015; Imtenan et al. 2014).

The toxicity of any inhaled environmental agent is the result of its interaction with the respiratory tract, which is in constant contact with the air. The resulting toxicity is thus the result of the agent’s properties on one hand, and of the properties or working principle of the respiratory tract on the other. Before giving an overview of the molecular and cellular mechanisms by which diesel engine emissions affect human health, we will give a brief overview on the composition and physicochemical characteristics of diesel exhaust, as well as on the human respiratory tract and its functional properties that are most relevant to the inhalation of air pollutants and the attributed health effects.

Diesel exhaust composition

Diesel exhaust is a complex mixture, but is made up of three fractions: solid, condensed (or liquid), and gaseous fractions (Chan et al. 2007; Westerholm and Egeback 1994; Jayaram et al. 2011). The solid fraction mainly consists of primary particles with a core of about 10–30 nm in diameter composed of elemental carbon present in a graphitized form (Zhu et al. 2005; Liati and Eggenschwiler 2010). The primary particles can then agglomerate and form larger soot aggregates with mean diameters of 60–100 nm (Burtscher 2005; van Setten et al. 2001), which are the main cause of the black appearance of unfiltered diesel exhaust (Fig. 1). The exact mechanisms underlying the formation of soot are complex and only partly understood. The main pathway appears to be pyrolyzation of unburnt fuel and lubrication oil, mainly to ethyne, followed by polymerization reactions, ring closure and stacking of the resulting polycyclic, graphite-like sheets in a turbostrated structure. In addition to the elemental carbon in the soot particles, the solid fraction of diesel exhaust contains metal and metal-oxides originating from lubrication and fuel additives and from engine wear. Fuel and lubrication oil additives contain metals as functional components, such as zinc, and magnesium in oils and cerium, iron, manganese, platinum and copper in fuels (Mayer et al. 2010). At the high temperatures present in the combustion chamber, these additives may be subject to vaporization, condensation and nucleation processes, resulting in their embedding into the carbonaceous soot particles and in the formation of metal and/or metal-oxide nucleation mode particles with diameters ranging down to 10 nm (Burtscher 2005; Mayer et al. 2010; Maricq 2007). In addition, wear on the engine, which is predominantly made up of iron (Okuda et al. 2009), produces particles in the size range of 1–2 µm and higher, which may be subject to the same processes as the metals in fuel and lubrication oil additives and may ultimately also participate in the formation of nanosized particles and the enrichment of the carbonaceous soot particles with iron and iron oxides (Mayer et al. 2010).
Fig. 1

Diesel particles collected on a filter from an unfiltered diesel passenger car, driven for 30 min, resulting in approximately 5 mg of particles (a) and transmission electron micrograph of diesel exhaust particles (b). The picture shows representative irregularly shaped elongated particle aggregates of ca. 200 nm length. The primary particles of about 20 nm are clearly identifiable

However, by far the most prevalent element to be found in the solid diesel exhaust particle fraction is elemental carbon, which is highly biopersistent. Therefore, whatever chemical compounds these particles contain, they will only to a limited extent dissolve in biofluids such as the lung-lining layer. As a consequence, even though the elemental composition is known to play a certain role in defining the toxicity of the solid particle cores (Steiner et al. 2012; Ma et al. 2014), it is not the main factor. It is instead the toxic compounds that adsorb on particle surfaces, as described later on, and the surface properties of the particles that deserve special attention. During the combustion process, but also later due to the presence of oxidizing gases and/or photochemical processes, the surfaces of the carbon particles become chemically activated, for example by the formation of quinones by the partial oxidation of particle-bound polyaromatic hydrocarbons (PAHs). Once activated, the particles participate in redox reactions, resulting in the formation of reactive oxygen species (ROS) such as hydrogen peroxide. Furthermore, the metals and metal-oxides—present as individual particles or embedded in carbon particles—participate in Fenton-type reactions by which the potency of the ROS is further increased (Geller et al. 2006; Antiñolo et al. 2015; Squadrito et al. 2001; McWhinney et al. 2013).

The gaseous exhaust fraction consists of more than 99 % by volume of non-toxic inorganic gases such as nitrogen, water and oxygen. Toxic inorganic gases such as carbon dioxide (CO2), carbon monoxide (CO), nitric oxide (NO) and nitrogen dioxide (NO2), and a complex mixture of organic compounds account for the rest. The organic fraction consists of small molecules such as methanol, ethylene or formaldehyde but mainly of larger aliphatic compounds and more complex molecules such as benzene, naphthalene, pyrene, anthracene and their various functionalized derivatives, collectively referred to as PAHs, nitrated polyaromatic hydrocarbons (NPAHs) and heterocyclic aromatic compounds (HACs) (Heeb et al. 2010; Westerholm and Egeback 1994; Vieira de Souza and Corrêa 2015; Heeb et al. 2008; Zielinska et al. 2004). Sources of the organic exhaust components are traces of fuel and lubrication oil that survived combustion, but also compounds that cannot be found in the fuel or oil and are newly formed from partially combusted precursors (Rhead and Hardy 2003).

With increasing molecular weight, and depending on their functionalization and the exhaust temperature, organic compounds may not be present as gases but are adsorbed onto soot, metal and metal-oxide particles or condense to form particles that together with water droplets comprise the liquid exhaust fraction (Burtscher 2005; Zielinska et al. 2004). Hence, for many of the organic exhaust components, a clear attribution to the gaseous or condensed fraction is difficult. Their distribution instead depends on the equilibrium between condensation and evaporation, which in turn is a function of exhaust temperature, exhaust concentration and the availability of nucleation centers and surfaces for condensation in the exhaust (e.g., particles).

The composition of all three exhaust fractions strongly depends on engine type and operation mode (inclusively electronic control and after-treatment systems), fuel and lubrication oil type and fuel and lubrication oil additives (Giakoumis et al. 2013; Popovicheva et al. 2015; Imtenan et al. 2014; Zhu et al. 2005; Mayer et al. 2010; Zielinska et al. 2004; Mathis et al. 2005; McClellan et al. 2012).

Revolutionary developments in exhaust after treatment have been done, and new engines with the best after-treatment systems emit substantially less PM and gaseous compounds (Khalek et al. 2015). Nonetheless, there is still a significant amount of older technology cars on the road, also actions to remove PM with a diesel particulate filter (DPF) usually result in an increase of NOx and vice versa and may form—tough fewer in number—different kinds of particles (McClellan et al. 2012; Khalek et al. 2011).

The respiratory system

It is important to highlight certain aspects of the lung structure in order to understand how diesel exhaust can interact with lung cells and possible resulting adverse effects.

The respiratory tract provides an enormous internal surface of ca. 150 m2 that is optimized for facile exchange of gases between inhaled air and the bloodstream (Gehr et al. 1978). It can broadly be subdivided into the nasopharyngeal, the tracheobronchial and the alveolar regions (Oberdorster et al. 2005). The tracheobronchial region can further be subdivided into the trachea, the bronchi (main, lobar, segmental bronchi and bronchioles), and the alveolar region into alveolar bronchioles and the alveoli. Gas exchange between inhaled air and the bloodstream only takes place in the alveolar bronchioles and the alveoli (Rothen-Rutishauser et al. 2008).

Given the large surface area the respiratory tract represents, the importance of efficient mechanisms for avoiding the entry of airborne pollutants—primarily particulate ones—is evident. A first line of defense, active in the nasopharyngeal and the upper tracheobronchial region, is comprised by sneezing and coughing. Once the lower tracheobronchial region is penetrated, inhaled particles may be trapped in the mucus lining of the airway epithelium. This filtration of particles from the inhaled air is of different efficiency for different particles sizes and in different regions of the respiratory tract (Oberdorster et al. 2005; Carvalho et al. 2011). As a consequence, different regions of the respiratory tract will be exposed to different size ranges of particles: the nasopharyngeal region mainly to particles larger than 500 nm and smaller than 5 nm, the tracheobronchial region mainly to particles in the size range of 1–50 nm, and the alveolar region mainly to particles in the size range of 5–500 nm (Oberdorster et al. 2005; Patton and Byron 2007).

Even though a large fraction of airborne particles is filtered from the inhaled air and eliminated via the mucociliary escalator, bronchiolar and alveolar deposition of particles still occurs and the mechanisms responsible for their clearance changes gradually from the nasopharyngeal to the most peripheral (alveolar) region. Clearance of deposited particles from the airways is fast (within minutes) and is mainly achieved by the ciliary movement of the mucus toward the pharynx where it is swallowed together with any deposited material (Kilburn 1968). The mucociliary activity gradually declines from the bronchiolar to the alveolar region and in the alveoli, epithelial clearance fully relies on other mechanisms, mainly on the action of lung-resident professional phagocytes, the alveolar macrophages that can engulf inhaled diesel particles. These cells patrol the luminal side of the lung epithelium and take up any deposited material they encounter and together with pulmonary dendritic cells, collaborate as sentinels against deposited fine particles (Rothen-Rutishauser et al. 2008; Moller et al. 2008; Ochs and Weibel 2008; Vermaelen et al. 2001). This clearance is considerably slower (over weeks or months) than the mucociliary elevator, which allows the particles to interact with the respiratory epithelium for prolonged periods of time (Moller et al. 2008). Besides possible chemical interactions, it has been shown that deposited particles may translocate across the epithelium into the connective tissue, the bloodstream or the lymphatic circulation (Oberdorster et al. 2005) and that they may be taken up by various cell types other than macrophages, for instance epithelial cells of the respiratory tract (Lehmann et al. 2009; Fig. 2). Exactly how this happens is not well understood but appears to involve active and passive processes (Muhlfeld et al. 2008).
Fig. 2

After deposition in the respiratory tract, diesel exhaust particles are normally cleared from the epithelium by the mucociliary escalator or by phagocytosis by resident macrophages. Other cell types may, however, also take up the particles, which due to their biopersistence results in particle accumulation in the tissue and thereby extensive exposure to the redox-active particle surfaces. The figure shows transmission electron micrographs of diesel exhaust particles that were taken up in vitro by bronchial epithelial cells (cell line 16HBE14o–). The picture on the right shows a magnified part of the picture on the left [adapted from Lehmann et al. (2009)]

Taken together, the nature of the mechanisms for protection and clearance has important consequences for how air pollution interacts with the respiratory system:
  1. 1.

    They only work for particulate air pollution but cannot defend the organism against adverse effects of gaseous compounds. In fact, due to the function of the lungs, gases must be able to freely enter the respiratory system and the respiratory epithelium is specifically designed to allow efficient exchange of gases between the inhaled air and the bloodstream.

     
  2. 2.

    Airborne particles reach different regions of the respiratory system depending on their size. Smaller particles reach more peripheral regions of the lung than larger particles.

     

As a consequence, the occurrence of adverse effects of diesel exhaust is not only a function of the overall concentration of many different chemical species, but also of the combined effects of the gaseous, liquid and particulate exhaust fraction and how individual compounds are distributed between them. Since the particle size ultimately determines the major site of deposition, the overall particle number-size distribution as well as the allocation of individual compounds to specific size classes is of importance in addition.

Mechanisms underlying adverse effects of air pollution

Epidemiological studies conducted over the last two decades have shown a positive correlation between the level of particulate air pollution and increased adverse health effects (Dockery et al. 1993; Bremner et al. 1999; Braga et al. 2000), including increased pulmonary diseases (Choudhury et al. 1997; Pope et al. 1999), as well as a rise in the number of deaths from cardiovascular disease (Abbey et al. 1999; Aga et al. 2003; Zanobetti et al. 2003; Kaiser et al. 2004). Based on the proven genotoxicity of its constituents, diesel exhaust has been judged as mutagenic and carcinogenic to humans by the World Health Organization (WHO 2010, 2010) and in June 2012, the International Agency for Research on Cancer (IARC) classified diesel engine exhaust as a group 1 carcinogen to humans (2013), predominantly based upon epidemiological studies (Attfield et al. 2012; Silverman et al. 2012), supported by a large number of experimental studies (Hemmingsen et al. 2011; Sevastyanova et al. 2008; Topinka et al. 2012; Fall et al. 2007; Risom et al. 2003).

The exact causal connection between air pollution—including diesel exhaust—and adverse health effects is still not fully understood, but certain molecular and cellular mechanisms are generally assumed to play a key role. In the following, these mechanisms will be described with an emphasis on why diesel exhaust—at least in its non-treated form (i.e., generated in absence of filtration or catalytic converters) represents a worst-case scenario for respiratory health.

The most well-described cellular responses upon interaction with diesel exhaust are the induction of pulmonary oxidative stress and (pro-)inflammation, both of which are known to be involved in the onset or exacerbation of respiratory diseases such chronic obstructive pulmonary disease (COPD), but also in the (air pollution-related) development of systemic effects such as cardiovascular diseases or thrombosis. A further relevant reaction is the induction of genotoxicity, which is partly also linked to oxidative stress and (pro-)inflammation and may ultimately result in the onset of lung cancer (Moller et al. 2008; Schwarze et al. 2013). None of the three endpoints are specific to diesel exhaust, but apply for all kinds of air pollution or inhaled agents with adverse health effects (such as tobacco smoke) and will therefore be described in a generalized manner.

A detailed description on how pulmonary oxidative stress, (pro)inflammation and genotoxicity result in specific pathologies, for instance Chronic Obstructive Pulmonary Disease (COPD), other fibrotic disorders or lung cancer, is beyond the scope of this article, and we will only provide an overview on the link between air pollution and the three mentioned endpoints. For further reading, comprehensive literature on our current understanding of the occurrence of a wide array of fibrotic respiratory disorders (Bonner 2007) as a consequence of pulmonary oxidative stress, inflammation and genotoxicity, including COPD (Decramer et al. 2008; Yang et al. 2011; Gan et al. 2004; Kersul et al. 2011; Wedzicha and Seemungal 2007) and asthma (Alexis and Carlsten 2014; McCreanor et al. 2007), but also lung cancer (Silverman et al. 2012; Attfield et al. 2012; Silverman et al. 2014) and systemic complications such as cardiovascular diseases (Brito et al. 2010; Miller et al. 2015; Chin 2015; Tong et al. 2014; Haberzettl et al. 2014) and thrombosis (Mills et al. 2007), is available elsewhere (Fig. 3).
Fig. 3

Inhalation of diesel exhaust directly affects the respiratory tract by inducing local oxidative stress, (pro-)inflammatory signaling and genotoxicity, which ultimately may result in respiratory diseases such as COPD, asthma and lung cancer. Exhaust components (particles and gases) are also translocated across airway and respiratory epithelia and enter the circulatory system, along with locally produced (pro-)inflammatory signaling molecules and oxidizing molecules that are either actively produced by lung-resident immune cells or are products of redox reactions triggered by exhaust components. The bloodstream distributes these molecules throughout the whole body, resulting in systemic oxidative stress and inflammation and genotoxic effects in organs other than the lung. The ultimate result may be systemic health effects such as cardiovascular diseases, thrombosis, stroke, cancer or accelerated aging

Pulmonary oxidative stress and (pro-)inflammation

Even in 1990s it was recognized that adverse health effects caused by particulate air pollution rely on pulmonary inflammation (Seaton et al. 1995), but the underlying mechanisms were not known at that time. In 1994, Oberdorster et al. (1994) demonstrated that intratracheal instillation of ultrafine titanium dioxide (TiO2) particles with average diameters of about 20 nm resulted in significantly stronger inflammatory responses in mice than the identical mass of fine TiO2 particles with average diameters of about 250 nm. They realized that this pointed toward the particles’ surface area as relevant factor in particle toxicology, i.e., their chemical composition was not the only important factor. Subsequent research identified the induction of oxidative stress, i.e., the formation of reactive oxygen and nitrogen species (ROS/RNS), as a main factor determining particle toxicity. This finding was in perfect agreement with the fact that particle toxicity increases with the particle surface area, since the formation of ROS and RNS at particle surfaces was known to occur (Donaldson et al. 2002).

A direct connection between inflammatory processes and oxidative stress was subsequently also suggested by Xiao et al. (2003) and could explain effects of particle inhalation (Oberdorster et al. 2005; Schins 2002; Schins and Knaapen 2007; Donaldson et al. 2005). Based on their results, it is assumed that ROS formed at the surfaces of redox cycling particles, depending on the extent of their formation, cause either the activation of antioxidant defense mechanisms (at low levels of oxidative stress), (pro-)inflammatory responses (at intermediate levels of oxidative stress) or exert cytotoxic effects (at high levels of oxidative stress). Importantly, an additional promoter of the impact of the smaller fraction of particles is their retention time in the alveolar region and their ability to translocate across the respiratory epithelium and/or enter cells, where they may accumulate over time. Depending on their solubility and biodegradability, which for instance is extremely low for the carbon particles in diesel exhaust, they may remain there for years and exert adverse effects.

ROS and RNS are not only formed at particle surfaces. Many gases in diesel exhaust are themselves ROS or RNS (for instance ozone and NO2), while many hydrocarbons, volatile and dissolved from particle surfaces, may actively participate in redox cycling and/or may act as potent electrophiles. Furthermore, metal ions dissolved from particles may catalyze the formation of ROS (Shinyashiki et al. 2009).

The fact that adverse effects of inhaled pollutants are not restricted to the respiratory system could furthermore be attributed to (pro-)inflammatory cytokines, the mediators of inflammation, being distributed via the bloodstream from the respiratory tract to the whole body, causing systemic inflammation. Also the translocation of particles into the blood stream and the resulting induction of systemic oxidative stress have been shown to be involved (Miller et al. 2015; Haberzettl et al. 2014; Simkhovich et al. 2008; Kunzli and Tager 2005). Translocation of molecular oxidants—either present in the inhaled air or formed in the respiratory tract in response to the inhalation of oxidants—may act in the same way. In addition, once inflammatory reactions are triggered, activated immune cells produce ROS and RNS as a part of the immune response, by which the level of oxidative stress may be increased endogenously and oxidative stress may be induced locally in the respiratory tract or systemically (Weitzman and Gordon 1990; Bogdan et al. 2000).

Oxidative-stress-independent induction of pulmonary inflammation

While the above-described model assumes oxidative stress to be the trigger for the induction of pulmonary inflammation, more recent studies have shown that PAHs may initiate (pro-)inflammatory reactions but do not form ROS or RNS on their own (Podechard et al. 2008; Tsuji et al. 2011). This was found to rely on the activation of (pro-)inflammatory signaling cascades via highly specific interactions between certain PAHs and the intracellular aryl hydrocarbon receptor (AhR) present in many cell types. Interestingly, activation of the AhR signaling pathway results in the intracellular formation of ROS (Nebert et al. 2004), which play an active role as secondary messengers, i.e., they regulate cellular events downstream from the AhR. One of these events is the activation of nuclear factor kappaB (NFκB), one of the key inducers of inflammatory responses (Kalthoff et al. 2010; Stockinger et al. 2011); and indeed it was shown that when cells are treated with antioxidant agents in addition to PAHs, the pro-inflammatory responses are inhibited (Podechard et al. 2008). (Pro-)inflammatory stimulation by complex aerosols is therefore likely to be the result of the combined action of particle-mediated ROS formation and ROS-independent mechanisms.

Pulmonary genotoxicity

Cancer, including lung cancer, may arise as a result of genotoxicity, the introduction of damages, or changes in the genomic DNA of cells.

An important mechanism underlying genotoxicity relies on oxidative and alkylating DNA damages, which are introduced by organic radicals, ROS and RNS (inhaled or endogenously formed by immune cells or the cellular metabolism), that attack double bonds of purine or pyrimidine bases or cause DNA strand breaks (Reuter et al. 2010; Xue and Warshawsky 2005). The direct action of ROS/RNS as well as intercalation and adduct formation by aromatic organic compounds is referred to as primary genotoxicity, whereas the action of ROS/RNS produced by immune cells in response to (pro-)inflammatory stimulation is classified as secondary genotoxicity (Schins 2002; Schins and Knaapen 2007).

Electrophilic breakage of double bonds results in the formation of adduct radicals which react further to various products that ultimately may cause DNA polymerases to misread the nucleotide sequence during DNA replication and may hence result in the incorporation of the wrong bases (Donaldson et al. 2005; Shinyashiki et al. 2009; Xue and Warshawsky 2005; Cooke et al. 2003; Kasai 2002). Biomolecules other than DNA may be oxidized as well. For instance, peroxidation of polyunsaturated fatty acids results in the formation of reactive aldehydes such as acrolein or crotonaldehyde, which may react with DNA and result in the formation of exocyclic DNA adducts (Nair et al. 2007).

Furthermore, the activity of PAHs, NPAH, and HACs may cause genotoxicity in a way that is less dependent on the presence of oxidizing agents or even oxidative stress. These molecules may directly interact with DNA by intercalation between the stacked bases, DNA adduct formation and/or the formation of abasic sites (Xue and Warshawsky 2005; Ferguson and Denny 2007). The ultimate result is the loss of bases or the incorporation of additional or wrong bases during DNA replication.

Methods to assess exhaust toxicity

With the known adverse effects caused by the emissions of internal combustion engines toward human health and the environment—and the resulting exhaust emission legislation of increasing stringency—new or optimized technologies are being developed almost on a daily basis. These technologies include highly efficient exhaust after-treatment systems (e.g., diesel particle filters, selective catalytic converters), new engine technologies providing optimized combustion, but also new fuel types (e.g., biodiesel), all of which aim at reducing the net mass emissions of particles, CO, CO2, NO, NO2, and organic compounds. All of these may result in profound changes in the exhaust composition and whereas the overall reduction in mass emission brought about by new technologies can be measured with relative ease, it is much more difficult to describe how they affect exhaust toxicity, which is clearly the ultimate objective behind exhaust emission legislation.

The basic mechanisms underlying adverse health effects described above provide a valuable (but not exhaustive) set of markers based on which exhaust toxicity can be assessed, i.e., the quantification of (pro-)inflammatory molecules, oxidized biomolecules or DNA damages upon a test system (such as an animal, a cell culture or a cell-free solution of, for instance, DNA) exposed to an exhaust sample. Biochemical methods for assessing these markers (and many others not listed in this review) have been developed, validated and standardized over the past few decades; the bioanalytical aspect is therefore not the greatest challenge when measuring exhaust toxicity.

As is the case for any toxicological experiment, experiments for exhaust toxicity assessment should be designed in a way that they (1) simulate real-world exposure conditions as closely as possible, (2) provide a high level of reproducibility, and (3) are representative for the species of interest, in most cases humans. Simulations of real-world conditions depend on how a test sample of the substance under investigation is produced or collected, and how and at which dose it is administered to the biological test system. The experimental reproducibility and the relevance of the experiment with respect to the species of interest are to a large degree determined by the choice of the test system and the endpoints taken into account.

The high complexity of diesel exhaust, particularly the presence of the dynamically interacting gaseous and particulate fractions, renders adequate sample preparation highly challenging. In order to simulate real-world conditions, it is obviously best performed by sampling exhaust from a test vehicle operated on-road. The exhaust samples should be diluted in a way that does not influence the exhaust particle number-size distribution (Fujitani et al. 2009). Diluted exhaust samples can then either directly be used for exposure experiments or treated in a manner reflecting processes of photo- and atmospheric chemistry that take place under real-world conditions and result in the formation of secondary organic aerosols (SOA) not present in the original exhaust (Zhang et al. 2014; Robinson et al. 2007; Jathar et al. 2014; Atkinson and Arey 1994).

Such close simulation of real-world conditions is, however, difficult to achieve and in many cases is unfeasible. For example, on-road operation of the test vehicle will decrease the experimental reproducibility. In practice, the test vehicle is therefore usually operated on a dynamometer, either under steady-state conditions or running a standardized test cycle. Real-world simulation of the exhaust dilution will decrease exhaust concentrations to such an extent [roughly 1:10,000 (Zhang and Wexler 2004)] that exposure experiments would have to be conducted for very long periods of time in order to obtain detectable effects. Studies performed with complete exhaust (in many studies, sampled exhaust particles or extracts thereof are used instead) therefore usually work with final particle concentrations of 100–300 µg/m3, which is considerably higher than the real-world concentrations where the daily average of Particulate Matter 10 (PM10) should not exceed 20–25 µg/m3 (depending on the country) (Hesterberg et al. 2009; Paur et al. 2011). Photo- and atmospheric chemistry is usually neglected, unless a study specifically investigates such effects.

Experimental reproducibility is influenced by the sample preparation, the exposure method and the biological test system. As long as exhaust samples are produced on a dynamometer, considerable variation between individual samples is unlikely. The same applies for the exposure method, which can be standardized to a high degree. The choice of the biological test system therefore deserves special attention, also with regard to its relevance.

Basically, three different choices are possible: epidemiological studies (the biological system is a specific cohort population), in vivo (where the biological system is an animal or a human) and in vitro studies (where the biological system is a cell or bacterial culture). Epidemiological studies, while certainly providing the most relevant results with respect to public health, are not feasible for the assessment of exhaust toxicity of a specific engine technology, fuel or exhaust after-treatment system The effects of a new technology should be investigated prior to its widespread use; however, epidemiological studies can only give retrospective estimates, i.e., only technologies that already are in widespread use can cause effects that may be detected in this way.

In vivo studies offer the advantage of testing on complete living organisms that comprise a whole regulatory network and are able to display all relevant responses to a given treatment. This renders the experimental relevance high, particularly when studies are performed with humans as test systems. However, human exposures, even though frequently performed (Hesterberg et al. 2009, 2010; Ghio et al. 2012) suffer from limited sample accessibility after exposure, which restricts the choice of biological endpoints. Also, such studies covering accumulative effects over the lifetime of an individual are practically unfeasible. In contrast, animal studies allow using the whole body as sample for biological investigation and because of the short lifetime of most model animals (for instance mice or rats), studies covering all developmental stages can be performed (e.g., the health effects institutes (HEI) exposures of new technology diesel exhaust (McDonald et al. 2015). These studies, however, suffer from a lack of comparability to humans with respect to the required doses and the resulting responses, both of which cannot necessarily be extrapolated between different species (Hesterberg et al. 2009; McGonigle and Ruggeri 2014). Both animal and human exposure studies additionally suffer from ethical concerns, are cost-intensive and usually cannot be performed with the high number of individuals that would be necessary to overcome the problem of inter-individual variation.

In vitro systems still provide only a (usually very small) part of the whole organism, hence systemic reactions, the buffering capacity of the whole organism (for example the possibility to detoxify certain compounds via the bloodstream and the liver) cannot, or can only partly, be simulated (Forbes 2000; Kim et al. 2014; Bakand et al. 2005). Further, in vitro systems usually do not allow a one-to-one simulation of the normal, in vivo method of sample administration as, for instance, the dynamics of exhaust inhalation cannot be fully reproduced.

Nevertheless, in vitro models are a valuable and indispensable alternative to in vivo studies. Perhaps the greatest advantage of in vitro systems is their high potential for standardization, which provides reproducibility and hence comparability of results, even if obtained by different research groups. Furthermore, the high efficiency, low cost and the absence of ethical concerns make in vitro systems very attractive, particularly for screening approaches on the results of which further studies can be designed.

Already in the 1950s, in their book ‘The Principles of Humane Experimental Techniques’, Burch and Russel (1959) introduced the “three Rs” (Reduction in the number of test animals, Refinement of test-protocols in order to minimize suffering and Replacement of animal tests) and thereby introduced the concept of alternatives to whole-animal test systems. Even though the principles initially received little attention, with the growth of the animal welfare movement in the 1970s the three Rs became a widely accepted ethical framework for conducting scientific experiments using animals humanely. Their existence has made and continues to make a significant contribution to the development of in vitro test methods (Bakand et al. 2005). In the course of this change in paradigm, a number of cell lines have been developed as in vitro models of drug and toxicity screening (Allen et al. 2008), and with respect to inhalation toxicology, in particular cell lines and ex vivo models representative for the (animal and human) respiratory tract (Rothen-Rutishauser et al. 2008; Muhlfeld et al. 2008; Forbes 2000; Constant et al. 2014; Alfaro-Moreno et al. 2008; Blank et al. 2006; Rothen-Rutishauser et al. 2005; Steimer et al. 2005). These models are being continuously improved upon and validated and are increasingly able to overcome the limitations generally suffered by in vitro models. In addition, since they are nowadays commonly used in combination with sophisticated aerosol exposure systems that can cope with many of the aforementioned challenges of sample processing (Asimakopoulou et al. 2011; Muller et al. 2010; Paur et al. 2008; Lichtveld et al. 2012; Aufderheide et al. 2003; Le Prieur et al. 2000; Cheng et al. 2003; Knebel et al. 2002; Holder et al. 2007), in vitro test methods are a reliable and indispensable tool for toxicity testing of air pollutants.

Conclusive remarks

While diesel engines offer great advantages—they are among the key technologies that make the modern world as we know it possible—they are also the source of highly potent air pollutants that affect the environment and public health on a large scale.

The great potency of diesel engine emissions as environmental toxicants is not simply the result of their chemical composition, but also relies on the structure–function relationships of the human respiratory tract and how the particulate fraction of diesel exhaust bypasses its defense mechanisms. Inhalable diesel exhaust particles are not efficiently filtered from the inhaled air, penetrate the respiratory tract deeply, deposit on or translocate across the lung epithelium and can evade otherwise efficient clearance mechanisms. By carrying condensed compounds of potentially high toxicity on their surfaces, these particles function like Trojan horses, allowing semi-volatile and nonvolatile chemicals access to organs, fluids and cellular compartments they could not reach without particles as carriers. The active surfaces of the highly biopersistent solid particle cores are also able to exert adverse effects on biofluids and cells for prolonged periods of time. The overall result is the induction of oxidative stress, pulmonary, systemic inflammation and, partly as a consequence of the latter two and partly via separate pathways, the damage of genomic DNA and thereby the potential formation of mutations and ultimately tumors.

This review has not covered the various efforts aimed at decreasing diesel exhaust toxicity by improved engine technologies and efficient exhaust after-treatment, as well as the ever-increasing stringency of exhaust emission legislation, which further accelerates the development of the latter technologies. The reductions in the emissions of toxic exhaust components achieved in recent years are impressive. Because of the high complexity of diesel engine emissions and the biological systems they interact with, it is unlikely that prediction of exhaust toxicity from exhaust composition will be possible in the near future, hence detailed toxicological studies will still be required. This need will become even more critical given the rapid changes in exhaust composition due to new technologies. Recent developments in the field of in vitro toxicology in combination with the availability of sophisticated aerosol exposure systems provides hope that even though exhaust toxicity will not be predictable in the near future, fast and reliable assessment of new technologies will be possible, and will allow exhaust emission legislation that effectively protects public health to be put in place.

Notes

Acknowledgments

This work was supported by the Adolphe Merkle Foundation, the Swiss Federal Office for the Environment (FOEN), VSS Lubes, and the Swiss Lung Foundation (Swiss Aerosol Award 2014 to Dr. Sandro Steiner).

References

  1. Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence Beeson W, Yang JX (1999) Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 159:373–382PubMedCrossRefGoogle Scholar
  2. Aga E, Samoli E, Touloumi G, Anderson H, Cadum E, Forsberg B, Goodman P, Goren A, Kotesovec F, Kriz B (2003) Short-term effects of ambient particles on mortality in the elderly: results from 28 cities in the APHEA2 project. Eur Respir J 21:28s–33sCrossRefGoogle Scholar
  3. Alexis NE, Carlsten C (2014) Interplay of air pollution and asthma immunopathogenesis: a focused review of diesel exhaust and ozone. Int Immunopharmacol 23:347–355PubMedCrossRefGoogle Scholar
  4. Alfaro-Moreno E, Nawrot TS, Vanaudenaerde BM, Hoylaerts MF, Vanoirbeek JA, Nemery B, Hoet PHM (2008) Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. Eur Respir J 32:1184–1194PubMedCrossRefGoogle Scholar
  5. Allen DD, Caviedes R, Caedenas AM, Shimahara T, Segura-Aguilar J, Caviedes PA (2008) Cell lines as in vitro models for drug screening and toxicity studies (vol 31, pg 757, 2005). Drug Dev Ind Pharm 34:234CrossRefGoogle Scholar
  6. Antiñolo M, Willis MD, Zhou S, Abbatt JP (2015) Connecting the oxidation of soot to its redox cycling abilities. Nature communications 6:6812PubMedPubMedCentralCrossRefGoogle Scholar
  7. Ashraful AM, Masjuki HH, Kalam MA (2015) Particulate matter, carbon emissions and elemental compositions from a diesel engine exhaust fuelled with diesel–biodiesel blends. Atmos Environ 120:463–474CrossRefGoogle Scholar
  8. Asimakopoulou A, Daskalos M, Chasapidis L, Akritidis T, Vlachos ND, Papaioannou E, Konstandopoulos A (2011) Characterization of a multiculture in vitro cell exposure chamber for assessing the biological impact of diesel engine exhaust. In: InternationalConferenceonSafeProductionandUseofNanomaterials, Journal of PhysicsGoogle Scholar
  9. Atkinson R, Arey J (1994) Atmospheric chemistry of gas-phase polycyclic aromatic-hydrocarbons: formation of atmospheric mutagens. Environ Health Perspect 102:117–126PubMedPubMedCentralCrossRefGoogle Scholar
  10. Attfield MD, Schleiff PL, Lubin JH, Blair A, Stewart PA, Vermeulen R, Coble JB, Silverman DT (2012a) The Diesel Exhaust in Miners study: a cohort mortality study with emphasis on lung cancer. J Natl Cancer Inst 104:869–883PubMedPubMedCentralCrossRefGoogle Scholar
  11. Attfield MD, Schleiff PL, Lubin JH, Blair A, Stewart PA, Vermeulen R, Coble JB, Silverman DT (2012b) The diesel exhaust in miners study: a cohort mortality study with emphasis on lung cancer. J Natl Cancer I 104:869–883CrossRefGoogle Scholar
  12. Aufderheide M, Knebel JW, Ritter D (2003) Novel approaches for studying pulmonary toxicity in vitro. Toxicol Lett 140:205–211PubMedCrossRefGoogle Scholar
  13. Bakand S, Winder C, Khalil C, Hayes A (2005) Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: a review. Inhal Toxicol 17:775–787PubMedCrossRefGoogle Scholar
  14. Blank F, Rothen-Rutishauser BM, Schurch S, Gehr P (2006) An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 19:392–405PubMedCrossRefGoogle Scholar
  15. Bogdan C, Rollinghoff M, Diefenbach A (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity (vol 12, pg 64, 2000). Curr Opin Immunol 12:604CrossRefGoogle Scholar
  16. Bonner JC (2007) Lung fibrotic responses to particle exposure. Toxicol Pathol 35:148–153PubMedCrossRefGoogle Scholar
  17. Braga A, Zanobetti A, Schwartz J (2000) Do respiratory epidemics confound the association between air pollution and daily deaths? Eur Respir J 16:723–728PubMedCrossRefGoogle Scholar
  18. Bremner SA, Anderson H, Atkinson R, McMichael A, Strachan D, Bland J, Bower J (1999) Short-term associations between outdoor air pollution and mortality in London 1992-4. Occup Environ Med 56:237–244PubMedPubMedCentralCrossRefGoogle Scholar
  19. Brijesh P, Sreedhara S (2013) Exhaust emissions and its control methods in compression ignition engines: a review. Int J Automot Technol 14:195–206CrossRefGoogle Scholar
  20. Brito JM, Belotti L, Toledo AC, Antonangelo L, Silva FS, Alvim DS, Andre PA, Saldiva PHN, Rivero DHRF (2010) Acute cardiovascular and inflammatory toxicity induced by inhalation of diesel and biodiesel exhaust particles. Toxicol Sci 116:67–78PubMedCrossRefGoogle Scholar
  21. Burch RL, Russel WMS (1959) The principles of humane experimental technique. Methuen, London, UKGoogle Scholar
  22. Burtscher H (2005) Physical characterization of particulate emissions from diesel engines: a review. J Aerosol Sci 36:896–932CrossRefGoogle Scholar
  23. Cames M, Helmers E (2013) Critical evaluation of the European diesel car boom—global comparison, environmental effects and various national strategies. Environ Sci Eur 25:15CrossRefGoogle Scholar
  24. Carvalho TC, Peters JI, Williams Iii RO (2011) Influence of particle size on regional lung deposition: what evidence is there? Int J Pharm 406:1–10PubMedCrossRefGoogle Scholar
  25. Chan TL, Ning Z, Wang JS, Cheung CS, Leung CW, Hung WT (2007) Gaseous and particle emission factors from the selected on-road petrol/gasoline, diesel, and liquefied petroleum gas vehicles. Energy Fuels 21:2710–2718CrossRefGoogle Scholar
  26. Cheng MD, Malone B, Storey JME (2003) Monitoring cellular responses of engine-emitted particles by using a direct air-cell interface deposition technique. Chemosphere 53:237–243PubMedCrossRefGoogle Scholar
  27. Chin MT (2015) Basic mechanisms for adverse cardiovascular events associated with air pollution. Heart 101:253–256PubMedCrossRefGoogle Scholar
  28. Choudhury AH, Gordian ME, Morris SS (1997) Associations between respiratory illness and PM10 air pollution. Arch Environ Health 52:113–117PubMedCrossRefGoogle Scholar
  29. Constant S, Wiszniewski L, Huang S (2014) The Use of in vitro 3D cell models of human airway epithelia (MucilAirTM) in inhalation toxicity. In: Haycock J, Ahluwalia A, Wilkinson M (eds) Cellular in vitro testing: methods and protocols. CRC Press, London, UK, pp 15–33Google Scholar
  30. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRefGoogle Scholar
  31. Decramer M, Nici L, Nardini S, Reardon J, Rochester CL, Sanguinetti CM, Troosters T (2008) Targeting the COPD exacerbation. Respir Med 102(Suppl 1):S3–S15PubMedCrossRefGoogle Scholar
  32. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE (1993) An association between air pollution and mortality in six US cities. N Engl J Med 329:1753–1759PubMedCrossRefGoogle Scholar
  33. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, Tran L, Stone V (2002) The pulmonary toxicology of ultrafine particles. J Aerosol Med 15:213–220PubMedCrossRefGoogle Scholar
  34. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V (2005) Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2:10PubMedPubMedCentralCrossRefGoogle Scholar
  35. Dwivedi G, Sharma M, Jain S (2013) Diesel engine performance and emission analysis using biodiesel from various oil sources—review. J Mater Environ Sci 4:434–447Google Scholar
  36. Fall M, Haddouk H, Morin JP, Forster R (2007) Mutagenicity of benzyl chloride in the Salmonella/microsome mutagenesis assay depends on exposure conditions. Mutat Res 633:13–20PubMedCrossRefGoogle Scholar
  37. Ferguson LR, Denny WA (2007) Genotoxicity of non-covalent interactions: DNA intercalators. Mutat Res 623:14–23PubMedCrossRefGoogle Scholar
  38. Forbes II (2000) Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharm Sci Technolo Today 3:18–27PubMedCrossRefGoogle Scholar
  39. Fujitani Y, Hirano S, Kobayashi S, Tanabe K, Suzuki A, Furuyama A, Kobayashi T (2009) Characterization of dilution conditions for diesel nanoparticle inhalation studies. Inhal Toxicol 21:200–209PubMedCrossRefGoogle Scholar
  40. Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580PubMedPubMedCentralCrossRefGoogle Scholar
  41. Gehr P, Bachofen M, Weibel ER (1978) The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol 32(2):121–140Google Scholar
  42. Geller MD, Ntziachristos L, Mamakos A, Samaras Z, Schmitz DA, Froines JR, Sioutas C (2006) Physicochemical and redox characteristics of particulate matter (PM) emitted from gasoline and diesel passenger cars. Atmos Environ 40:6988–7004CrossRefGoogle Scholar
  43. Ghio AJ, Smith CB, Madden MC (2012) Diesel exhaust particles and airway inflammation. Curr Opin Pulm Med 18:144–150PubMedCrossRefGoogle Scholar
  44. Giakoumis EG, Rakopoulos CD, Dimaratos AM, Rakopoulos DC (2013) Exhaust emissions with ethanol or n-butanol diesel fuel blends during transient operation: a review. Renew Sustain Energy Rev 17:170–190CrossRefGoogle Scholar
  45. Haberzettl P, Bhatnagar A, Conklin D (2014) Particulate matter and oxidative stress–pulmonary and cardiovascular targets and consequences. In: Laher I (ed) Systems biology of free radicals and antioxidants. Springer, Berlin, Heidelberg, pp 1557–1586CrossRefGoogle Scholar
  46. Heeb NV, Schmid P, Kohler M, Gujer E, Zennegg M, Wenger D, Wichser A, Ulrich A, Gfeller U, Honegger P, Zeyer K, Emmenegger L, Petermann JL, Czerwinski J, Mosimann T, Kasper M, Mayer A (2008) Secondary effects of catalytic diesel particulate filters: conversion of PAHs versus formation of Nitro-PAHs. Environ Sci Technol 42:3773–3779PubMedCrossRefGoogle Scholar
  47. Heeb NV, Schmid P, Kohler M, Gujer E, Zennegg M, Wenger D, Wichser A, Ulrich A, Gfeller U, Honegger P, Zeyer K, Emmenegger L, Petermann JL, Czerwinski J, Mosimann T, Kasper M, Mayer A (2010) Impact of low- and high-oxidation diesel particulate filters on genotoxic exhaust constituents. Environ Sci Technol 44:1078–1084PubMedCrossRefGoogle Scholar
  48. Heeb NV, Zennegg M, Haag R, Wichser A, Schmid P, Seiler C, Ulrich A, Honegger P, Zeyer K, Emmenegger L, Bonsack P, Zimmerli Y, Czerwinski J, Kasper M, Mayer A (2013) PCDD/F formation in an iron/potassium-catalyzed diesel particle filter. Environ Sci Technol 47:6510–6517PubMedGoogle Scholar
  49. Hemmingsen JG, Moller P, Nojgaard JK, Roursgaard M, Loft S (2011) Oxidative stress, genotoxicity, and vascular cell adhesion molecule expression in cells exposed to particulate matter from combustion of conventional diesel and methyl ester biodiesel blends. Environ Sci Technol 45:8545–8551PubMedCrossRefGoogle Scholar
  50. Hesterberg TW, Long CM, Bunn WB, Sax SN, Lapin CA, Valberg PA (2009) Non-cancer health effects of diesel exhaust: a critical assessment of recent human and animal toxicological literature. Crit Rev Toxicol 39:195–227PubMedCrossRefGoogle Scholar
  51. Hesterberg TW, Long CM, Lapin CA, Hamade AK, Valberg PA (2010) Diesel exhaust particulate (DEP) and nanoparticle exposures: what do DEP human clinical studies tell us about potential human health hazards of nanoparticles? Inhal Toxicol 22:679–694PubMedCrossRefGoogle Scholar
  52. Holder AL, Lucas D, Goth-Goldstein R, Koshland CP (2007) Inflammatory response of lung cells exposed to whole, filtered, and hydrocarbon denuded diesel exhaust. Chemosphere 70:13–19PubMedCrossRefGoogle Scholar
  53. Imtenan S, Varman M, Masjuki HH, Kalam MA, Sajjad H, Arbab MI, Rizwanul Fattah IM (2014) Impact of low temperature combustion attaining strategies on diesel engine emissions for diesel and biodiesels: a review. Energy Convers Manag 80:329–356CrossRefGoogle Scholar
  54. Jathar SH, Gordon TD, Hennigan CJ, Pye HO, Pouliot G, Adams PJ, Donahue NM, Robinson AL (2014) Unspeciated organic emissions from combustion sources and their influence on the secondary organic aerosol budget in the United States. Proc Natl Acad Sci 111:10473–10478PubMedPubMedCentralCrossRefGoogle Scholar
  55. Jayaram V, Agrawal H, Welch WA, Miller JW, Cocker DR (2011) Real-time gaseous, PM and ultrafine particle emissions from a modern marine engine operating on biodiesel. Environ Sci Technol 45:2286–2292PubMedCrossRefGoogle Scholar
  56. Kaiser R, Romieu I, Medina S, Schwartz J, Krzyzanowski M, Künzli N (2004) Air pollution attributable postneonatal infant mortality in US metropolitan areas: a risk assessment study. Environ Health 3:4PubMedPubMedCentralCrossRefGoogle Scholar
  57. Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP (2010) Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10. J Biol Chem 285:5993–6002PubMedPubMedCentralCrossRefGoogle Scholar
  58. Kasai H (2002) Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis. Free Radic Biol Med 33:450–456PubMedCrossRefGoogle Scholar
  59. Kersul AL, Iglesias A, Rios A, Noguera A, Forteza A, Serra E, Agusti A, Cosio BG (2011) Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 47:176–183PubMedCrossRefGoogle Scholar
  60. Khalek IA, Bougher TL, Merritt PM, Zielinska B (2011) Regulated and unregulated emissions from highway heavy-duty diesel engines complying with US Environmental Protection Agency 2007 emissions standards. J Air Waste Manag Assoc 61:427–442PubMedCrossRefGoogle Scholar
  61. Khalek IA, Blanks MG, Merritt PM, Zielinska B (2015) Regulated and unregulated emissions from modern 2010 emissions-compliant heavy-duty on-highway diesel engines. J Air Waste Manag Assoc 65:987–1001PubMedPubMedCentralCrossRefGoogle Scholar
  62. Kilburn KH (1968) A hypothesis for pulmonary clearance and its implications. Am Rev Respir Dis 98:449–463PubMedGoogle Scholar
  63. Kim JA, Salvati A, Aberg C, Dawson KA (2014) Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety. Nanoscale 6:14180–14184PubMedCrossRefGoogle Scholar
  64. Knebel JW, Ritter D, Aufderheide M (2002) Exposure of human lung cells to native diesel motor exhaust: development of an optimized in vitro test strategy. Toxicol Vitro 16:185–192CrossRefGoogle Scholar
  65. Kunzli N, Tager IB (2005) Air pollution: from lung to heart. Swiss Med Wkly 135:697–702PubMedGoogle Scholar
  66. Le Prieur E, Vaz E, Bion A, Dionnet F, Morin J-P (2000) Toxicity of diesel engine exhausts in an in vitro model of lung slices in biphasic organotypic culture: induction of a proinflammatory and apoptotic response. Arch Toxicol 74:460–466PubMedCrossRefGoogle Scholar
  67. Lehmann AD, Blank F, Baum O, Gehr P, Rothen-Rutishauser BM (2009) Diesel exhaust particles modulate the tight junction protein occludin in lung cells in vitro. Part Fibre Toxicol 6:1–14CrossRefGoogle Scholar
  68. Liati A, Eggenschwiler PD (2010) Characterization of particulate matter deposited in diesel particulate filters: visual and analytical approach in macro-, micro- and nano-scales. Combust Flame 157:1658–1670CrossRefGoogle Scholar
  69. Lichtveld KM, Ebersviller SM, Sexton KG, Vizuete W, Jaspers I, Jeffries HE (2012) In vitro exposures in diesel exhaust atmospheres: resuspension of PM from filters versus direct deposition of PM from air. Environ Sci Technol 46:9062–9070PubMedPubMedCentralCrossRefGoogle Scholar
  70. Ma JYC, Young S-H, Mercer RR, Barger M, Schwegler-Berry D, Ma JK, Castranova V (2014) Interactive effects of cerium oxide and diesel exhaust nanoparticles on inducing pulmonary fibrosis. Toxicol Appl Pharmacol 278:135–147PubMedPubMedCentralCrossRefGoogle Scholar
  71. Maricq MM (2007) Chemical characterization of particulate emissions from diesel engines: a review. J Aerosol Sci 38:1079–1118CrossRefGoogle Scholar
  72. Mathis U, Mohr M, Forss AM (2005) Comprehensive particle characterization of modern gasoline and diesel passenger cars at low ambient temperatures. Atmos Environ 39:107–117CrossRefGoogle Scholar
  73. Mayer A, Czerwinski J, Wichser A, Ulrich A, Kasper M, Mooney J (2010) Metal-oxide particles in combustion engine exhaust. SAE Technical Papers 2010-01-0792Google Scholar
  74. McClellan RO, Hesterberg TW, Wall JC (2012) Evaluation of carcinogenic hazard of diesel engine exhaust needs to consider revolutionary changes in diesel technology. Regul Toxicol Pharmacol 63:225–258PubMedCrossRefGoogle Scholar
  75. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, Stewart-Evans J, Malliarou E, Jarup L, Harrington R, Svartengren M, Han I-K, Ohman-Strickland P (2007) Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med 357:2348–2358PubMedCrossRefGoogle Scholar
  76. McDonald JD, Doyle-Eisele M, Seagrave J, Gigliotti AP, Chow J, Zielinska B, Mauderly JL, Seilkop SK, Miller RA, Committee HHR (2015) Part 1. Assessment of carcinogenicity and biologic responses in rats after lifetime inhalation of new-technology diesel exhaust in the ACES bioassay. Res Rep Health Eff Inst 184:9–44PubMedGoogle Scholar
  77. McGonigle P, Ruggeri B (2014) Animal models of human disease: challenges in enabling translation. Biochem Pharmacol 87:162–171PubMedCrossRefGoogle Scholar
  78. McWhinney RD, Badali K, Liggio J, Li SM, Abbatt JP (2013) Filterable redox cycling activity: a comparison between diesel exhaust particles and secondary organic aerosol constituents. Environ Sci Technol 47:3362–3369PubMedGoogle Scholar
  79. Miller M, McLean SG, Shaw CA, Duffin R, Lawal AO, Araujo JA, Hadoke PWF, Newby DE (2015) Diesel exhaust particles impair vascular function and promote atherosclerosis through generation of oxidative stress. Atherosclerosis 241:e137–e138CrossRefGoogle Scholar
  80. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, Boon NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE (2007) Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med 357:1075–1082PubMedCrossRefGoogle Scholar
  81. Moller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Haussinger K, Kreyling WG (2008) Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 177:426–432PubMedCrossRefGoogle Scholar
  82. Muhlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P (2008) Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol-Lung C 294:L817–L829CrossRefGoogle Scholar
  83. Muller L, Comte P, Czerwinski J, Kasper M, Mayer ACR, Gehr P, Burtscher H, Morin JP, Konstandopoulos A, Rothen-Rutishauser B (2010) New exposure system to evaluate the toxicity of (scooter) exhaust emissions in lung cells in vitro. Environ Sci Technol 44:2632–2638PubMedCrossRefGoogle Scholar
  84. Myung CL, Park S (2012) Exhaust nanoparticle emissions from internal combustion engines: a review. Int J Automot Technol 13:9–22CrossRefGoogle Scholar
  85. Nair U, Bartsch H, Nair J (2007) Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 43:1109–1120PubMedCrossRefGoogle Scholar
  86. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847–23850PubMedCrossRefGoogle Scholar
  87. Oberdorster G, Ferin J, Lehnert BE (1994) Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102(Suppl 5):173–179PubMedPubMedCentralCrossRefGoogle Scholar
  88. Oberdorster G, Oberdorster E, Oberdorster J (2005a) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839PubMedPubMedCentralCrossRefGoogle Scholar
  89. Oberdorster G, Oberdorster E, Oberdorster J (2005b) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839PubMedPubMedCentralCrossRefGoogle Scholar
  90. Ochs M, Weibel ER (eds) (2008) Fishman’s pulmonary diseases and disorders, vol 4. McGraw-Hill, New YorkGoogle Scholar
  91. Okuda T, Schauer JJ, Olson MR, Shafer MM, Rutter AP, Walz KA, Morschauser PA (2009) Effects of a platinum–cerium bimetallic fuel additive on the chemical composition of diesel engine exhaust particles. Energy Fuels 23:4974–4980CrossRefGoogle Scholar
  92. Pant P, Harrison RM (2012) Critical review of receptor modelling for particulate matter: a case study of India. Atmos Environ 49:1–12CrossRefGoogle Scholar
  93. Patton JS, Byron PR (2007) Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67–74PubMedCrossRefGoogle Scholar
  94. Paur HR, Mulhopt S, Weiss C, Diabate S (2008) In vitro exposure systems and bioassays for the assessment of toxicity of nanoparticles to the human lung. J Verbrauch Lebensm 3:319–329CrossRefGoogle Scholar
  95. Paur HR, Cassee FR, Teeguarden J, Fissan H, Diabate S, Aufderheide M, Kreyling WG, Hanninen O, Kasper G, Riediker M, Rothen-Rutishauser B, Schmid O (2011) In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung-A dialog between aerosol science and biology. J Aerosol Sci 42:668–692CrossRefGoogle Scholar
  96. Podechard N, Lecureur V, Le Ferrec E, Guenon I, Sparfel L, Gilot D, Gordon JR, Lagente V, Fardel O (2008) Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. Toxicol Lett 177:130–137PubMedCrossRefGoogle Scholar
  97. Pope CA, Verrier RL, Lovett EG, Larson AC, Raizenne ME, Kanner RE, Schwartz J, Villegas GM, Gold DR, Dockery DW (1999) Heart rate variability associated with particulate air pollution. Am Heart J 138:890–899PubMedCrossRefGoogle Scholar
  98. Popovicheva O, Engling G, Lin K-T, Persiantseva N, Timofeev M, Kireeva E, Völk P, Hubert A, Wachtmeister G (2015) Diesel/biofuel exhaust particles from modern internal combustion engines: microstructure, composition, and hygroscopicity. Fuel 157:232–239CrossRefGoogle Scholar
  99. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer How are they linked? Free Radic Biol Med 49:1603–1616PubMedPubMedCentralCrossRefGoogle Scholar
  100. Rhead MM, Hardy SA (2003) The sources of polycyclic aromatic compounds in diesel engine emissions. Fuel 82:385–393CrossRefGoogle Scholar
  101. Risom L, Dybdahl M, Bornholdt J, Vogel U, Wallin H, Moller P, Loft S (2003) Oxidative DNA damage and defence gene expression in the mouse lung after short-term exposure to diesel exhaust particles by inhalation. Carcinogenesis 24:1847–1852PubMedCrossRefGoogle Scholar
  102. Robinson AL, Donahue NM, Shrivastava MK, Weitkamp EA, Sage AM, Grieshop AP, Lane TE, Pierce JR, Pandis SN (2007) Rethinking organic aerosols: semivolatile emissions and photochemical aging. Science 315:1259–1262PubMedCrossRefGoogle Scholar
  103. Rothen-Rutishauser BM, Kiama SG, Gehr P (2005) A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol 32:281–289CrossRefGoogle Scholar
  104. Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P (2008) In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol 4:1075–1089PubMedCrossRefGoogle Scholar
  105. Schins RPF (2002) Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol 14:57–78PubMedCrossRefGoogle Scholar
  106. Schins RPF, Knaapen AM (2007) Genotoxicity of poorly soluble particles. Inhal Toxicol 19:189–198PubMedCrossRefGoogle Scholar
  107. Schwarze PE, Totlandsdal AI, Lag M, Refsnes M, Holme JA, Ovrevik J (2013) Inflammation-related effects of diesel engine exhaust particles: studies on lung cells in vitro. Biomed Res Int 2013:1–13CrossRefGoogle Scholar
  108. Seaton A, Macnee W, Donaldson K, Godden D (1995) Particulate air-pollution and acute health-effects. Lancet 345:176–178PubMedCrossRefGoogle Scholar
  109. Sevastyanova O, Novakova Z, Hanzalova K, Binkova B, Sram RJ, Topinka J (2008) Temporal variation in the genotoxic potential of urban air particulate matter. Mutat Res 649:179–186PubMedCrossRefGoogle Scholar
  110. Shinyashiki M, Eiguren-Fernandez A, Schmitz DA, Di Stefano E, Li N, Linak WP, Cho SH, Froines JR, Cho AK (2009) Electrophilic and redox properties of diesel exhaust particles. Environ Res 109:239–244PubMedCrossRefGoogle Scholar
  111. Silverman DT, Lubin JH, Blair AE, Vermeulen R, Stewart PA, Schleiff PL, Attfield MD (2014) Re: the Diesel Exhaust in Miners Study (DEMS): a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer I 106:dju205CrossRefGoogle Scholar
  112. Silverman DT, Samanic CM, Lubin JH, Blair AE, Stewart PA, Vermeulen R, Coble JB, Rothman N, Schleiff PL, Travis WD, Ziegler RG, Wacholder S, Attfield MD (2012) The diesel exhaust in miners study: a nested case–control study of lung cancer and diesel exhaust. J Natl Cancer Inst 104:855–868Google Scholar
  113. Simkhovich BZ, Kleinman MT, Kloner RA (2008) Air pollution and cardiovascular injury. J Am Coll Cardiol 52:719–726PubMedCrossRefGoogle Scholar
  114. Squadrito GL, Cueto R, Dellinger B, Pryor WA (2001) Quinoid redox cycling as a mechanism for sustained free radical generation by inhaled airborne particulate matter. Free Radic Biol Med 31:1132–1138PubMedCrossRefGoogle Scholar
  115. Steimer A, Haltner E, Lehr CM (2005) Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med 18:137–182PubMedCrossRefGoogle Scholar
  116. Steiner S, Mueller L, Popovicheva OB, Raemy DO, Czerwinski J, Comte P, Mayer A, Gehr P, Rothen-Rutishauser B, Clift MJD (2012) Cerium dioxide nanoparticles can interfere with the associated cellular mechanistic response to diesel exhaust exposure. Toxicol Lett 214:218–225PubMedCrossRefGoogle Scholar
  117. Stockinger B, Hirota K, Duarte J, Veldhoen M (2011) External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin Immunol 23:99–105PubMedCrossRefGoogle Scholar
  118. Tong H, Rappold AG, Caughey M, Hinderliter AL, Graff DW, Berntsen JH, Cascio WE, Devlin RB, Samet JM (2014) Cardiovascular effects caused by increasing concentrations of diesel exhaust in middle-aged healthy GSTM1 null human volunteers. Inhal Toxicol 26:319–326PubMedCrossRefGoogle Scholar
  119. Topinka J, Milcova A, Schmuczerova J, Mazac M, Pechout M, Vojtisek-Lom M (2012) Genotoxic potential of organic extracts from particle emissions of diesel and rapeseed oil powered engines. Toxicol Lett 212:11–17PubMedCrossRefGoogle Scholar
  120. Tsuji G, Takahara M, Uchi H, Takeuchi S, Mitoma C, Moroi Y, Furue M (2011) An environmental contaminant, benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway. J Dermatol Sci 62:42–49PubMedGoogle Scholar
  121. van Setten BAAL, Makkee M, Moulijn JA (2001) Science and technology of catalytic diesel particulate filters. Catal Rev 43:489–564CrossRefGoogle Scholar
  122. Varatharajan K, Cheralathan M (2012) Influence of fuel properties and composition on NOx emissions from biodiesel powered diesel engines: a review. Renew Sustain Energy Rev 16:3702–3710CrossRefGoogle Scholar
  123. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA (2001) Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 193:51–60PubMedPubMedCentralCrossRefGoogle Scholar
  124. Vieira de Souza C, Corrêa SM (2015) Polycyclic aromatic hydrocarbon emissions in diesel exhaust using gas chromatography–mass spectrometry with programmed temperature vaporization and large volume injection. Atmos Environ 103:222–230CrossRefGoogle Scholar
  125. Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370:786–796PubMedCrossRefGoogle Scholar
  126. Weitzman SA, Gordon LI (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655–663PubMedGoogle Scholar
  127. Westerholm R, Egeback KE (1994) Exhaust emissions from light-duty and heavy-duty vehicles: chemical-composition, impact of exhaust after treatment, and fuel parameters. Environ Health Perspect 102:13–23PubMedPubMedCentralCrossRefGoogle Scholar
  128. WHO (2010) Environmental health criteria 202, selected non-heterocyclic polycyclic aromatic hydrocarbons. http://www.who.int/ipcs/publications/ehc
  129. WHO (2010) Environmental health criteria 229, selected nitro- and nitro-oxy-polycyclic aromatic hydrocarbonsGoogle Scholar
  130. Wierzbicka A, Nilsson PT, Rissler J, Sallsten G, Xu Y, Pagels JH, Albin M, Österberg K, Strandberg B, Eriksson A, Bohgard M, Bergemalm-Rynell K, Gudmundsson A (2014) Detailed diesel exhaust characteristics including particle surface area and lung deposited dose for better understanding of health effects in human chamber exposure studies. Atmos Environ 86:212–219CrossRefGoogle Scholar
  131. Xiao GG, Wang M, Li N, Loo JA, Nel AE (2003) Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem 278:50781–50790PubMedCrossRefGoogle Scholar
  132. Xue WL, Warshawsky D (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206:73–93PubMedCrossRefGoogle Scholar
  133. Yang IA, Relan V, Wright CM, Davidson MR, Sriram KB, Savarimuthu Francis SM, Clarke BE, Duhig EE, Bowman RV, Fong KM (2011) Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 15:439–456PubMedCrossRefGoogle Scholar
  134. Yin JX, Harrison RM, Chen Q, Rutter A, Schauer JJ (2010) Source apportionment of fine particles at urban background and rural sites in the UK atmosphere. Atmos Environ 44:841–851CrossRefGoogle Scholar
  135. Zanobetti A, Schwartz J, Samoli E, Gryparis A, Touloumi G, Peacock J, Anderson RH, Le Tertre A, Bobros J, Celko M (2003) The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environ Health Perspect 111:1188PubMedPubMedCentralCrossRefGoogle Scholar
  136. Zhang KM, Wexler AS (2004) Evolution of particle number distribution near roadways—part I: analysis of aerosol dynamics and its implications for engine emission measurement. Atmos Environ 38:6643–6653CrossRefGoogle Scholar
  137. Zhang H, Zhang Z, Cui T, Lin Y-H, Bhathela NA, Ortega J, Worton DR, Goldstein AH, Guenther A, Jimenez JL (2014) Secondary organic aerosol formation via 2-methyl-3-buten-2-ol photooxidation: evidence of acid-catalyzed reactive uptake of epoxides. Environ Sci Technol Lett 1:242–247PubMedPubMedCentralCrossRefGoogle Scholar
  138. Zhu JY, Lee KO, Yozgatligil A, Choi MY (2005) Effects of engine operating conditions on morphology, microstructure, and fractal geometry of light-duty diesel engine particulates. Proc Combust Inst 30:2781–2789CrossRefGoogle Scholar
  139. Zielinska B, Sagebiel J, Arnott WP, Rogers CF, Kelly KE, Wagner DA, Lighty JS, Sarofim AF, Palmer G (2004) Phase and size distribution of polycyclic aromatic hydrocarbons in diesel and gasoline vehicle emissions. Environ Sci Technol 38:2557–2567PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Sandro Steiner
    • 1
  • Christoph Bisig
    • 1
  • Alke Petri-Fink
    • 1
  • Barbara Rothen-Rutishauser
    • 1
  1. 1.Adolphe Merkle InstituteUniversity of FribourgFribourgSwitzerland

Personalised recommendations